These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Proteomic analysis of outer membrane proteins and vesicles of a clinical isolate and a collection strain of Stenotrophomonas maltophilia. Ferrer-Navarro M; Torrent G; Mongiardini E; Conchillo-Solé O; Gibert I; Daura X J Proteomics; 2016 Jun; 142():122-9. PubMed ID: 27185551 [TBL] [Abstract][Full Text] [Related]
4. A Stenotrophomonas maltophilia Strain Evades a Major Caenorhabditis elegans Defense Pathway. White CV; Darby BJ; Breeden RJ; Herman MA Infect Immun; 2016 Feb; 84(2):524-36. PubMed ID: 26644380 [TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates. Cantón R; Valdezate S; Vindel A; Sánchez Del Saz B; Maíz L; Baquero F Pediatr Pulmonol; 2003 Feb; 35(2):99-107. PubMed ID: 12526070 [TBL] [Abstract][Full Text] [Related]
6. Diffusible signal factor-dependent cell-cell signaling and virulence in the nosocomial pathogen Stenotrophomonas maltophilia. Fouhy Y; Scanlon K; Schouest K; Spillane C; Crossman L; Avison MB; Ryan RP; Dow JM J Bacteriol; 2007 Jul; 189(13):4964-8. PubMed ID: 17468254 [TBL] [Abstract][Full Text] [Related]
7. Immunostimulatory properties of the emerging pathogen Stenotrophomonas maltophilia. Waters VJ; Gómez MI; Soong G; Amin S; Ernst RK; Prince A Infect Immun; 2007 Apr; 75(4):1698-703. PubMed ID: 17220304 [TBL] [Abstract][Full Text] [Related]
8. Risk factors for levofloxacin resistance in Stenotrophomonas maltophilia from respiratory tract in a regional hospital. Pien CJ; Kuo HY; Chang SW; Chen PR; Yeh HW; Liu CC; Liou ML J Microbiol Immunol Infect; 2015 Jun; 48(3):291-5. PubMed ID: 24239064 [TBL] [Abstract][Full Text] [Related]
9. Isolation and Characterization of Stenotrophomonas maltophilia Isolates from a Brazilian Hospital. Gallo SW; Figueiredo TP; Bessa MC; Pagnussatti VE; Ferreira CA; Oliveira SD Microb Drug Resist; 2016 Dec; 22(8):688-695. PubMed ID: 27007167 [TBL] [Abstract][Full Text] [Related]
10. Molecular Characterization of Stenotrophomonas maltophilia isolates from cystic fibrosis patients and the hospital environment. Marzuillo C; De Giusti M; Tufi D; Giordano A; Del Cimmuto A; Quattrucci S; Mancini C; Villari P Infect Control Hosp Epidemiol; 2009 Aug; 30(8):753-8. PubMed ID: 19583515 [TBL] [Abstract][Full Text] [Related]
11. Pan-Resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia Infection in Cystic Fibrosis Does Not Reduce Survival After Lung Transplantation. Lobo LJ; Tulu Z; Aris RM; Noone PG Transplantation; 2015 Oct; 99(10):2196-202. PubMed ID: 25856407 [TBL] [Abstract][Full Text] [Related]
12. Characterization of small-colony-variant Stenotrophomonas maltophilia isolated from the sputum specimens of five patients with cystic fibrosis. Anderson SW; Stapp JR; Burns JL; Qin X J Clin Microbiol; 2007 Feb; 45(2):529-35. PubMed ID: 17135443 [TBL] [Abstract][Full Text] [Related]
13. Levofloxacin Efflux and smeD in Clinical Isolates of Stenotrophomonas maltophilia. Chong SY; Lee K; Chung HS; Hong SG; Suh Y; Chong Y Microb Drug Resist; 2017 Mar; 23(2):163-168. PubMed ID: 27294684 [TBL] [Abstract][Full Text] [Related]
14. The Ax21 protein is a cell-cell signal that regulates virulence in the nosocomial pathogen Stenotrophomonas maltophilia. McCarthy Y; Dow JM; Ryan RP J Bacteriol; 2011 Nov; 193(22):6375-8. PubMed ID: 21908663 [TBL] [Abstract][Full Text] [Related]
15. Stenotrophomonas maltophilia. An SQ; Berg G Trends Microbiol; 2018 Jul; 26(7):637-638. PubMed ID: 29754971 [TBL] [Abstract][Full Text] [Related]
16. Stenotrophomonas maltophilia: to be or not to be a cystic fibrosis pathogen. Hansen CR Curr Opin Pulm Med; 2012 Nov; 18(6):628-31. PubMed ID: 22990659 [TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of virulence determinants of Stenotrophomonas maltophilia strains isolated from patients affected by cystic fibrosis. Di Bonaventura G; Prosseda G; Del Chierico F; Cannavacciuolo S; Cipriani P; Petrucca A; Superti F; Ammendolia MG; Concato C; Fiscarelli E; Casalino M; Piccolomini R; Nicoletti M; Colonna B Int J Immunopathol Pharmacol; 2007; 20(3):529-37. PubMed ID: 17880766 [TBL] [Abstract][Full Text] [Related]
18. [Analysis of acquired resistance genes in Stenotrophomonas maltophilia]. Song JH; Sung JY; Kwon KC; Park JW; Cho HH; Shin SY; Ko YH; Kim JM; Shin KS; Koo SH Korean J Lab Med; 2010 Jun; 30(3):295-300. PubMed ID: 20603591 [TBL] [Abstract][Full Text] [Related]
19. Stenotrophomonas maltophilia: antimicrobial resistance and molecular typing of an emerging pathogen in a Turkish university hospital. Gülmez D; Hasçelik G Clin Microbiol Infect; 2005 Nov; 11(11):880-6. PubMed ID: 16216102 [TBL] [Abstract][Full Text] [Related]
20. An overview of various typing methods for clinical epidemiology of the emerging pathogen Stenotrophomonas maltophilia. Gherardi G; Creti R; Pompilio A; Di Bonaventura G Diagn Microbiol Infect Dis; 2015 Mar; 81(3):219-26. PubMed ID: 25592000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]